Citation:
Cannon JW, Zhung J, Bennett J, Moreland NJ, Baker MG, Geelhoed E, ..... Carapetis JR, et al. The economic and health burdens of diseases caused by group A Streptococcus in New Zealand. Int J Infect Dis. 2021;103:176-81.
Keywords:
Cellulitis; Children; Economic burden; Group A Streptococcus; Health burden; Rheumatic fever; Skin infections
Abstract:
In preparation for the future arrival of a group A Streptococcus (GAS) vaccine, this study estimated the economic and health burdens of GAS diseases in New Zealand. The annual incidence of GAS diseases was based on extrapolation of the average number of primary healthcare episodes managed each year in general practices (2014-2016) and on the average number of hospitalizations occurring each year (2005-2014). Disease incidence was multiplied by the average cost of diagnosing and managing an episode of disease at each level of care to estimate the annual economic burden.
The economic and health burdens of diseases caused by group A Streptococcus in New Zealand
In preparation for the future arrival of a group A Streptococcus (GAS) vaccine, this study estimated the economic and health burdens of GAS diseases in New Zealand. The annual incidence of GAS diseases was based on extrapolation of the average number of primary healthcare episodes managed each year in general practices (2014-2016) and on the average number of hospitalizations occurring each year (2005-2014). Disease incidence was multiplied by the average cost of diagnosing and managing an episode of disease at each level of care to estimate the annual economic burden.